PDB39 Dosing Patterns Among Patients with Type 2 Diabetes (T2D) Initiating Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) in France and the Netherlands
Abstract
Authors
K. Norrbacka V. Divino J. Lebrec K. Vadher M. DeKoven